Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.32 CHF | +1.34% | +6.81% | +6.37% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.37% | 199B | |
+22.62% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.25% | 219B | |
-10.06% | 196B | |
-8.75% | 149B | |
-5.21% | 146B | |
+1.38% | 117B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Strikes $245 Million Settlement to End Antitrust Lawsuits Over Hypertension Drug Generics